Key Finding
SSRIs significantly reduced pain and depression in fibromyalgia compared to placebo, but showed no significant advantage over non-pharmacological interventions including acupuncture for treating depression.
Researchers reviewed nine studies involving 461 people with fibromyalgia to see whether antidepressant medications called SSRIs help with both chronic pain and depression. Fibromyalgia causes widespread body pain, fatigue, and mental fog, and many patients also struggle with depression. The studies compared SSRIs to placebo pills and to non-drug treatments including acupuncture and aerobic exercise.
The results showed that SSRIs were more effective than placebo at reducing both pain and depression symptoms in fibromyalgia patients. People taking SSRIs also reported better quality of life compared to those taking placebo. However, when SSRIs were compared directly to acupuncture and exercise, the differences weren't statistically significant—meaning these non-drug approaches performed similarly to medication for treating depression in fibromyalgia.
Importantly, patients taking SSRIs experienced more side effects, including digestive problems, dry mouth, drowsiness, sexual dysfunction, and headaches. More people dropped out of studies when taking SSRIs compared to other treatments.
What this means for patients: While SSRIs can help manage fibromyalgia symptoms, non-pharmacological options like acupuncture may offer comparable benefits for depression without the medication side effects. This research supports acupuncture as a viable alternative or complementary treatment for fibromyalgia-related depression and pain. The study quality was rated as low, so more rigorous research is needed to fully understand these treatment options. If considering acupuncture for fibromyalgia, seek a licensed acupuncturist with experience treating chronic pain conditions.
This systematic review and meta-analysis evaluated SSRI efficacy for fibromyalgia with comorbid depression and chronic pain. Nine RCTs (n=461, predominantly female, mean ages 32.7-52.9 years) were analyzed following PRISMA 2020 guidelines. Compared to placebo, SSRIs demonstrated statistically significant improvements in pain (8 RCTs, n=421; SMD -0.53, 95% CI: -0.92 to -0.14, p=0.007), depression (6 RCTs, n=265; SMD -0.67, 95% CI: -1.14 to -0.20, p=0.005), and quality of life (5 RCTs, n=301; SMD -0.30, 95% CI: -0.55 to -0.04, p=0.02). Notably, when compared to non-pharmacological interventions including acupuncture and aerobic exercise, SSRIs showed non-significant differences in depression outcomes (2 RCTs, n=70; SMD -0.39, 95% CI: -1.32 to 0.54, p=0.41). Evidence quality was very low to low due to heterogeneity and bias risk. SSRIs demonstrated higher adverse event rates and dropout rates. Clinical implication: Acupuncture may provide comparable antidepressant effects to SSRIs in fibromyalgia without pharmacological adverse effects.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 6-week integrative Korean medicine treatment centered on high-dose Angelica gigas produced clinically significant improvements in pain, function, and quality of life in a patient with 10-year treatment-refractory fibromyalgia unresponsive to opioid therapy.
📌 Left-sided auricular vagus nerve stimulation reduced pro-inflammatory cytokines and increased anti-inflammatory markers and BDNF in women with fibromyalgia, despite not producing superior pain relief compared to sham treatment.
📌 Laser acupuncture at 36.5 Hz pulsed frequency applied to Ryodoraku points significantly reduced pain intensity and fibromyalgia impact with large effect sizes (2.07-2.76) compared to education alone.